IFNG and myeloid sarcoma: They express MS susceptibility genes (e.g., interferon responsive genes), MHC-I genes thereby directly attracting cytotoxic CD8+ T cells, or Ifng-induced MHC-II genes thereby promoting CD4+ T cells.